Instil Bio, Inc.TILNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+28.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+28.5%/yr
Quarterly compound
Percentile
P86
Within normal range
vs 3Y Ago
2.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 28.63% |
| Q2 2025 | -252.59% |
| Q1 2025 | 60.27% |
| Q4 2024 | 47.55% |
| Q3 2024 | -89.72% |
| Q2 2024 | 26.26% |
| Q1 2024 | -7.56% |
| Q4 2023 | 7.24% |
| Q3 2023 | 26.25% |
| Q2 2023 | 43.57% |
| Q1 2023 | 6.26% |
| Q4 2022 | 9.54% |
| Q3 2022 | 13.51% |
| Q2 2022 | 14.15% |
| Q1 2022 | -28.65% |
| Q4 2021 | -45.57% |
| Q3 2021 | 8.78% |
| Q2 2021 | -81.76% |
| Q1 2021 | -5.39% |
| Q4 2020 | -132.52% |
| Q3 2020 | -120.85% |
| Q2 2020 | -43.56% |
| Q1 2020 | 0.00% |